Email ID
Password
Scrip   
Pfizer and generics – leveraging its established business
25 March 2009
Sita Shah

Pfizer is doing everything it can to prepare for a sales decline when its best-selling product Lipitor (atorvastatin) goes off patent. First it was the $68 billion acquisition of Wyeth, and now it is turning to generics through the recent licensing deal with Aurobindo Pharma.

After...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36